The use of nanotechnology to improve treatment efficacy and reduce side effects is central to
nanomedicine. In this context, stimuli-responsive drug delivery systems (DDS) such as …

Conventional drug delivery systems often have several pharmacodynamic and
pharmacokinetic limitations related to their low efficacy and bad safety. It is because these …

Over the past three decades, various photosensitive nanoparticles have been developed as
potential therapies in human health, ranging from photodynamic therapy technologies that …

Chemotherapeutic drugs are highly effective in treating cancer. However, the side effects
associated with this treatment lower the quality of life of cancer patients. Smart nanocarriers …

Over the last three decades, a handful of photochemical mechanisms have been applied to
a large number of nanoscale assemblies that encapsulate a payload to afford spatio …

Ultraviolet (UV) and near infrared (NIR) light-responsive polymeric nanomedicines (eg,
cargo-loaded micelles and vesicles) have increasingly received much attention for their …

Drug delivery systems (DDS) capable of releasing an active molecule at the appropriate site
and at a rate that adjusts in response to the progression of the disease or to certain …

The selective and efficient delivery of bioactive molecules to sites of interest remains a
formidable challenge in medicine. In recent years, it has been shown that stimuli-responsive …

Light is a particularly appealing tool for on‐demand drug delivery due to its noninvasive
nature, ease of application, and exquisite temporal and spatial control. Great progress is …

The need for sophisticated systems to improve drug delivery to the body is growing, as is the
complexity of therapeutic agents available to treat a variety of conditions. Among the …